Loading clinical trials...
Loading clinical trials...
A Randomized,Double-blind,Vehicle-controlled, Parallel-design,Multiple-site Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% (Douglas Pharmaceuticals America Ltd) to Ketoconazole Cream 2% (Teva Pharmaceuticals USA Inc.) in the Treatment of Tinea Pedis.
Conditions
Interventions
Experimental: Ketoconazole 2% Cream (Douglas Pharmaceuticals America Ltd.)
Active comparator: Ketoconazole 2% Cream (Teva Pharmaceuticals USA)
+1 more
Locations
3
United States
Moore Clinical Research
Brandon, Florida, United States
Moore Clinical Reseach
Tampa, Florida, United States
FXM Research International
Belize City, Belize
Start Date
December 11, 2019
Primary Completion Date
May 28, 2020
Completion Date
July 13, 2020
Last Updated
August 6, 2020
NCT07245667
NCT00233493
NCT03129321
NCT03897257
NCT00804193
NCT02842021
Lead Sponsor
Douglas Pharmaceuticals America Ltd
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions